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Figure 1.   A schematic of the N2 laser-based portable fluorimeter developed at the Centre for 
Advanced Technology, Indore, for in vivo clinical studies. 
 
fluorescence from the surface area directly illuminated 
by the excitation light. The light coming from the distal 
ends of the six collection fibers was imaged via a quartz 
lens system on the entrance slit of the spectrogra h 
whose output end wascoupled to the gateable intensi-
fied CCD camera. The delay between N2 laser pulse and 
the CCD camera shutter was adjusted to pick up fluo-
rescence and discriminate against ambient background 
light. The gate-width used was 200 ns. The common 
end of the fiber bundle was enclosed in an SS tube 
(9 mm outer diameter and 60 mm length). The tip of the 
probe was shielded by a 2 mm thick quartz optical flat, 
to provide a fixed distance between tissues and the fi-
bers for improved collection of fluorescence and also to 
protect contamination of the fiber tips with body fluids. 
The spectral data acquisition was computer controlled. 
The autofluorescence spectra were recorded with the tip 
of the fiber optic probe placed in contact with the tissue 
surface.  
The study involved 25 patients with histopathologi-
cally confirmed SCC of the oral cavity. An informed 
consent was obtained from all the patients who under-
went spectroscopic examination.  
Prior to recording spectra from a patient, the probe 
was disinfected with CIDEX (Johnso  and Johnson, 
India), washed with PBS and cleaned dry with a piece 
of sterilized cotton. A background spectrum was ac-
quired with the probe placed in air. It was subtracted 
from all subsequently acquired spectra. From each site, 
spectra were recorded for 30 s (i.e. 300 pulses) and 
were averaged to yield a single spectrum per site. The 
spectra were collected in the 350–700 nm spectral range 
with a resolution of ~2 nm. The signal-to-noise ratio 
was >100:1 at the fluorescence maximum. Before and 
after each measurement of tissue fluorescence, a spec-
trum was also acquired with the probe placed on the 
face of a quartz cuvette containing a known concentra-
tion of Rh-6G in ethyl alcohol. The spectrum from each 
tissue site was normalized with respect to the peak of 
the averaged Rh-6G spectrum. The intensity of fluores-
cence from each site is reported in this normalized unit. 
Spectra were collected from a total of 208 sites, of 
which 126 were from SCC and the remaining 82 were 
from the adjacent uninvolved normal region. On an av-
erage, 5 spectra from the cancerous tissue sites and 4 
spectra from the normal tissue sites were recorded. In 
each patient, the normal tissue sites interrogated were 
from the adjacent apparently uninvolved region of the 
oral cavity.  
The autofluorescence spectra recorded from different 
cancerous and normal sites of the oral cavity of a pa-
tient are shown in Figure 2 a and b, respectively. The 
con iderable site-to-site variation in the spectra is ap-
parent. The mean spectra for the cancerous sites and the 
normal sites from seven patients selected at random are 
shown in Figure 3 a and b, respectively. The differences 
in th  spectra from some of the normal and cancerous 
tissue sites are not that apparent, being masked by the 
large intra- and inter-patient variability in the intensity 
and line shape. While some of this variation may repre-
sent intrinsic variation in tissue fluorescence, the vari-
ble nature of the contact of the probe with the tissue 
surface in the clinical situation, will also add to the 
variation. It is pertinent to note that in the in vi ro stud-
ies on oral cavity tissues5, where the variability due to 
the nature of contact of the probe with the tissue surface 
will be minimal, a percentage variation )/( xs  of ~30% 
was observed in the spectrally integrated intensities 
(åI), from different sites of normal or cancerous tissues 
ov r the total sample size investigated. Here, x is the 
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Figure 2. N2 laser-excited autofluorescence spectra recorded from a, 
squamous cell carcinoma tissue sites; and b, uni volved tissue sites 
of the same patient. 
 
 
mean of åI values from different sites of one category 
and s is the standard deviation. In comparison, in the 
present in vivo study, the percentage variation )/( xs  in 
(åI) was ~60%. In order to ensure good discrimination, 
it is necessary to minimize these variations which may 
obscure the intercategory differences. In order to mini-
mize the inter- and intra-patient variability, a two-step 
procedure was adopted. In the first step, the spectrum 
from each site was normalized with respect to the spec-
trally integrated intensity from that site. This normaliza-
tion is expected to remove from the spectrum, the 
influence of the variable nature of the contact of the 
probe with the tissue surface and also lead to enhance-
ment of spectral features. Next, mean-scaling was per-
formed by calculating the mean spectrum for a patient 
(the average of the mean spectra from both cancerous 
and normal sites in that patient) and subtracting it from 
the spectrum of every site of the patient. Since mean-
scaling displays the differences in the fluorescence 
spectra for a particular diagnostic category with respect 
to the mean spectrum for that patient, it is expected to 
maximize the spectral differences between the two di-
agnostic categories. Indeed, normalization of the spectra 
with respect to their respective spectrally integrated 
intensities followed by mean scali g made the spectral 
differences between the two diagnostic categories much 
more apparent. In Figure 4 a and b, we show the auto-
fluorescence spectra of the cancerous and normal tissue
 
 
 
 
 
Figure 3.  Mean autofluorescence spectra of (a) squamous cell carci-
noma tissue sites; and (b) uninvolved tissue sites, from seven pa-
tients selected at random.  
 
sites after normalization. The corresponding normal-
ized, mean-scaled spectra are shown in Figure 5. As the 
mean normalized spectrum has been subtracted from 
each normalized spectrum corresponding to cancerous 
and normal oral cavity tissue sites from this patient, the 
ean now lies at y =0 over the entire emission wave-
length range. Evaluation of Figure 5 indicates that be-
tween 350 and 500 nm, the normalized, mean-sc led 
fluorescence intensity of the normal squamous tissue is 
less than the mean, and that of SCC is greater than the 
mean. 
In order to extract the diagnostic content of the auto-
fluorescence spectra of the cancerous and normal oral 
tissues, Principal Component Analysis (PCA)6 was em-
loyed. This procedure dimensionally reduces the spec-
tral data into a smaller orthogonal set of linear 
c mbinations of the emission variables that account for 
most of the variance of the spectral data set. For PCA, 
an input data matrix X(r ´ c) was created, such that each 
row of the matrix corresponded to the processed fluo-
rescence spectrum from each tissue site and each col-
umn corresponded to the processed fluorescence 
intensity at each emission wavelength.  
a 
b 
b 
a 
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Figure 4.  Normalized autofluorescence spectra from () squamous 
cell carcinoma tissue sites, and (b) uninvolved tissue sites of the 
same patient. 
 
 
 
Figure 5.  Mean-scaled, normalized autofluorescence spectra from 
squamous cell carcinoma tissue sites (solid line) and from normal 
(uninvolved) squamous tissue sites (dashed line) of the oral cavity of 
the same patient. 
 
The average values of principal components were 
calculated for each principal component for cancerous 
and normal squamous tissue. An unpaired two-tailed 
Student’s t test7 was employed to test the statistical 
significance of the differences between the means of the 
principal component scores, for cancerous and normal 
oral cavity tissue. PCA of normalized, mean-scaled 
spectra resulted in four principal components that col-
lectively accounted for 99% of the total variance of the 
spectral data. Of the four principal components, only 
two (PC-1 and PC-3) were found to have significantly 
different (P < 0.0001) values for SCC and normal 
squamous tissue. The differences in the values for the 
other two components (PC-2 and PC-4) for the two di-
agnostic categories were not significant (P > 0.01). 
Therefore, further analysis was carried out using PC-1 
and PC-3, which together accounted for 67% of the total 
variance, PC-1 accounting for 63% of the total variance 
and PC-3, the remaining 4%. 
Logistic discrimination was used to develop a classi-
fication algorithm to discriminate between the SCC tis-
sue sites and the normal squamous tissue sites. For two 
diagnostic categories, G1 and G2, the posterior probabil-
ity of being a member of G1, given scores x1 and x2 for 
the two principal compnents, is given by8: 
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where, P(x1, x2|Gi) is the conditional joint probability 
that a tissue sample of type i will have scores x1 and x2 
for the two principal components PC-1 and PC-3, re-
spectively, and P(Gi) is the prior probability of finding 
tissue type i in the sample population. P(x1, x2½Gi) is 
the product of the conditional probability of the two 
individual principal components of having scores x1 and 
x2, respectively. The prior probability is an estimate of 
the likelihood that a tissue sample of type i belongs to a 
particular group when no information about it is avail-
able. The total number of cases in each group were used 
to estimate the prior probabilities, assuming the sample 
size to be representative of sample population. C(i½j) is 
the cost of misclassifying a sample into group j, when it 
actually belongs to group i. The cost of misclassifica-
tion can be varied from 0 to 1 with the condition that, 
the sum of the cost of misclassification for all the diag-
nostic categories under consideration equals one. 
The posterior probabilities were determined by calcu-
lating the prior and the conditional joint probabilities 
and the costs of misclassification of the SCC tissue 
sites. The cost of misclassification of a particular tissue 
type was varied from 0 to 1 in increments of 0.05, and 
the optimal cost was identified when the number of 
misclassified samples was a minimum. If there was 
more than one cost at which the total number of mis-
classified samples was a minimum, then the cost at 
which the number of SCC tissue sites misclassified was 
a minimum was selected. The conditional probabilities 
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Figure 6.  Measured probability distributions of the scores of a, 
principal component-1 (PC-1) and b, principal component-3 (PC-3), 
for squamous cell carcinoma (SCC) tissue sites and normal (uni-
volved) squamous tissue sites. Solid line shows the fit to normal 
probability density function. 
 
 
were determined from the probability distribution of the 
principal component scores of each tissue type fitted to 
a normal probability density function9, which is charac-
terized by peak position (x) and width (s). The best fit 
of the normal probability density function to the prob-
ability distribution of the principal component scores of 
each tissue type was obtained in a least square sense, 
using x and s as free parameters of the fit. 
Figure 6 shows the measured probability distribution 
of PC-1 and PC-3 for normal squamous tissues and SCC 
of the oral cavity and its fit to a normal probability den-
sity function. Prior probabilities, determined by calcu-
lating the percentage of each tissue type from the data 
set, were 40% for normal squamous tissues and 60% for 
squamous carcinoma. The cost of misclassification was 
optimized at 0.36. Figure 7 shows the percentage of
 
Figure 7.  Percentage of the squamous cell carcinoma (SCC) and the 
normal squamous tissue sites classified correctly versus cost of mis-
classification of SCC tissue sites.  
 
 
Fig re 8.  Posterior probabilities of being classified as squamous 
cell carcinoma (SCC) for all tissue sites investigated. 
 
 
normal and cancerous oral tissues, correctly classified 
versus cost of misclassification of cancerous tissues, for 
the entire data set. It is evident from the figure that an 
increase in the cost of misclassification of cancerous 
tissues results in an increase in the proportion of cor-
rectly classified cancerous oral tissues and a decrease in 
the proportion of correctly classified normal oral tissues. 
In Figure 8 we plot the posterior probabilities for all the 
cancerous and the normal tissue sites of being classified as 
SCC. The figure indicates that 86% of the cancerous oral 
tissues have a posterior probability >0.5 and 63% of the 
normal oral tissues have a posterior probability <0.5.  
The reason for the relatively lower specificity values 
appears to be the fact that most of the patients who par-
ticipated in this study were at an advanced stage of ma-
lignancy. Some of the visually uninvolved sites 
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assumed to be normal may not be truly normal, since it 
is known that the ‘normal’ appearing region surround-
ing the cancerous tumour may have biochemical 
changes occurring due to the field- f ect of the malig-
nancy10. Indeed, when the discrimination analysis was 
carried out on the basis of the spectra averaged over all 
cancerous sites and the spectra averaged over all normal 
sites from a patient, a sensitivity and specificity towards 
cancer of 100% was obtained. The remarkably good 
results obtained on site-averaged spectra may suggest 
that a few of the normal sites had signatures very dif-
ferent from the other sites of the group. 
This pilot study shows that LIF can discriminate SCC 
of oral tissues from normal squamous tissues. However, 
since the objective of the LIF-based system is the early 
diagnosis of cancer, in the next stage of the study, a 
qualified doctor will locate the suspected region of the oral 
cavity using visual assessment or other conventional 
means. Before the biopsy is taken, autofluorescence spectra 
will be recorded from the suspected sites as well as several 
other surrounding normal sites. The biopsy specimens from 
the suspected regions will then be subjected to histopa-
thological examination and the spectral information will be 
correlated with the tissue histopathology to evaluate the 
true clinical potential of the LIF-based approach.  
To conclude, a pilot study to evaluate the clinical po-
tential of autofluorescence spectroscopy for diagnosis 
of cancer of oral cavity has been carried out using a 
system developed at the Centre for Advanced Technol-
ogy (CAT), Indore. In this study involving 25 patients 
with histopathologically confirmed cancer of oral cav-
ity, a sensitivity and specificity of 86% and 63%, re-
spectively, towards cancer was obtained. The relatively
lower specificity value appears to be due to the ad-
vanced stage of cancer in the patients investigated, due 
to which uninvolved regions treated as normal may not 
be truly normal. It will be desirable to carry out these 
studies in patients with early stages of cancer, to truly 
evaluate the diagnostic potential of the technique. 
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Most of the published work on transgenic wheat has 
used tissue culture responsive varieties such as 
‘Bobwhite’. The aim of the present study was to pro-
duce transgenic lines in modern high-yielding wheat 
cultivars irrespective of their tissue culture poten-
tial, using ‘Biolistic’ approach. Three of the highest 
y lding Indian wheat cultivars, namely CPAN 3004, 
Son lika and UP 2338 were chosen for transforma-
tion. Stable transgenic plants with bar (conferring 
resistance to herbicide Basta) and gus genes were 
produced in each of these cultivars. Earlier devel-
oped transformation and regeneration protocols for 
tissue culture responsive lines were modified for ob-
taining transformation frequenci s ranging from 
0.14 to 0.83%. These frequ ncies are comparable 
with the published reports using the most responsive 
lines. Analysis of co-segregation patterns for ba  and 
gus genes in the R1 progeny of a CPAN 3004 trans-
formant indicated integration at two different sites 
in the genome. While both the sites have functional 
gus gene, only one of these has a functional bar gene, 
giving 15:1 and 3:1 segregation ratios for the two 
genes, respectively. Expression of bar gene under the 
maize ubiquitin promoter was high enough to pro-
vide protection against topical application of 
250 mg/l gluphosinate ammonium, a concentratio  
that killed most of the weeds including Phalaris mi-
nor. 
 
PHALARIS minor commonly known as Gulli Danda or 
Gehun Ka Mama has established itself as the most pre-
dominant weed in the wheat fields along the Indo-
Gangetic plains. As a control measure, Isoproturon has 
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